Cue Health Inc
NASDAQ:HLTH
Cue Health Inc
Capital Expenditures
Cue Health Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Cue Health Inc
NASDAQ:HLTH
|
Capital Expenditures
-$63m
|
CAGR 3-Years
-177%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Capital Expenditures
-$735m
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-2%
|
|
Boston Scientific Corp
NYSE:BSX
|
Capital Expenditures
-$779m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-10%
|
|
Stryker Corp
NYSE:SYK
|
Capital Expenditures
-$612m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-11%
|
|
Abbott Laboratories
NYSE:ABT
|
Capital Expenditures
-$2.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Capital Expenditures
-$1.1B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-26%
|
See Also
What is Cue Health Inc's Capital Expenditures?
Capital Expenditures
-63m
USD
Based on the financial report for Dec 31, 2022, Cue Health Inc's Capital Expenditures amounts to -63m USD.
What is Cue Health Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-177%
Over the last year, the Capital Expenditures growth was 46%. The average annual Capital Expenditures growth rates for Cue Health Inc have been -177% over the past three years .